Steminent Biotherapeutics Inc. (TPEX:7729)
Taiwan · Delayed Price · Currency is TWD 88.10
-1.90 (-2.11%)
Jan 22, 2026, 1:08 PM CST
Steminent Biotherapeutics Company Description
Steminent Biotherapeutics Inc., operates as a biopharmaceutical company.
Its product pipeline includes Stemchymal for treatment for polyglutamine spinocerebellar ataxia, huntington's disease, osteoarthritis, acute syndromes, such as respiratory distress syndrome, liver failure, ischemic stoke.
The company was founded in 2009 and is based in Taipei, Taiwan.
Steminent Biotherapeutics Inc.
| Country | Taiwan |
| Founded | 2009 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Ling-Mei Wang |
Contact Details
Address: No.12, WenHu Street Taipei Taiwan | |
| Phone | 886 2 2627 9216 |
| Website | steminent.com |
Stock Details
| Ticker Symbol | 7729 |
| Exchange | Taipei Exchange |
| Reporting Currency | TWD |
| ISIN Number | TW0007729006 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Ling-Mei Wang | Chief Executive Officer |
| Yi-Chih Lo | Chief Financial Officer |